FSSNX
Price
$27.77
Change
-$0.31 (-1.10%)
Updated
Sep 20 closing price
RYMCX
Price
$8.57
Change
-$0.14 (-1.61%)
Updated
Sep 20 closing price
Ad is loading...

FSSNX vs RYMCX

Header iconFSSNX vs RYMCX Comparison
Open Charts FSSNX vs RYMCXBanner chart's image
Fidelity Small Cap Index
Price$27.77
Change-$0.31 (-1.10%)
VolumeN/A
CapitalizationN/A
Royce Micro-Cap Consult
Price$8.57
Change-$0.14 (-1.61%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSSNX vs RYMCX Comparison Chart
Loading...
VS
FSSNX vs. RYMCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a StrongBuy and RYMCX is a Buy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 27.3B vs. RYMCX (312M). FSSNX pays higher dividends than RYMCX: FSSNX (1.36) vs RYMCX (0.00). FSSNX was incepted earlier than RYMCX: FSSNX (13 years) vs RYMCX (26 years). RYMCX is a more actively managed with annual turnover of: 19.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than RYMCX: FSSNX (0) vs RYMCX (2000). FSSNX annual gain was more profitable for investors over the last year : 22.65 vs. RYMCX (10.01). FSSNX return over 5 years is better than : 44.62 vs. RYMCX (7.09).
FSSNXRYMCXFSSNX / RYMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years26 years-
Gain YTD9.9725.355186%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets27.3B312M8,750%
Annual Yield % from dividends1.360.00-
Returns for 1 year22.6510.01226%
Returns for 3 years0.65-27.88-2%
Returns for 5 years44.627.09629%
Returns for 10 years84.24-37.89-222%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD3.490.05
+1.45%
Relmada Therapeutics
BSAC20.240.18
+0.90%
Banco Santander-Chile
ODC67.85-0.79
-1.15%
Oil-Dri Corp
HRMY38.34-0.47
-1.21%
Harmony Biosciences Holdings
THAR2.94-0.05
-1.67%
Tharimmune Inc.